United Kingdom · Question · Written question
UIN 8825
Aldesleukin
Introduced
14 October 2024
Last action
23 October 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 October 2024
Summary
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the viability of aldesleukin as a routine treatment for people who have had a heart attack.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 October 2024
Written question
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the viability of aldesleukin as a routine treatment for people who have had a heart attack.
Source: Commons
23 October 2024
Answer
The National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre and the NIHR Cambridge Clinical Research Facility are supporting research into the benefits of low doses of aldesleukin for people who have experienced a heart...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-10-14/8825
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1733736
- uk · wq-1733736 · source updated 23 October 2024